Thrive Bioscience Raises $4.0 Million Seed Round

Thrive Bioscience Raises $4.0 Million Seed Round to Accelerate Product Development

Beverly, MA — August 18, 2015 — Thrive Bioscience, a NSIV biotech startup, announced the closing of a $4.0 million round of seed financing from angel groups, strategic partners and industry veterans that will accelerate commercialization of previously unavailable solutions by improving one of the most important research processes – cell culture.

To learn more about Thrive Bioscience and the impact of this important first round of financing, check out the full press release at www.thrivebio.com.